Literature DB >> 2714506

Fibrinopeptide A levels in maternal and newborn plasma.

P M Yuen1, J A Yin, T T Lao.   

Abstract

Plasma fibrinopeptide A (FPA), a dynamic measure of intravascular coagulation, was determined in 70 healthy Chinese women during normal pregnancy, labour, delivery and the early puerperium and compared to a group of healthy non-pregnant adult controls. In the normal controls the plasma FPA level (mean +/- SD) was 1.43 +/- 0.46 ng/ml. During pregnancy and labour, the FPA levels were 3.05 +/- 0.98 ng/ml and 11.47 +/- 4.43 ng/ml, respectively, and it reached a peak of 32.95 +/- 11.66 ng/ml at parturition, then falling to 6.15 +/- 2.52 ng/ml in the early puerperium. All these levels were significantly higher (p less than 0.001) compared to controls. Fifteen of the 21 mothers with blood sampling during parturition also had umbilical cord blood taken for determination of FPA level. There was no significant difference between the maternal (34.07 +/- 10.12 ng/ml) and cord (31.06 +/- 12.67 ng/ml) plasma FPA levels. It is concluded that the hypercoagulable state in women during pregnancy and the puerperium is associated with increased intravascular coagulation activity, and that increased intravascular coagulation activity also occurs in the fetus during parturition. This observation may account for the increased risk of thrombotic disorders observed in pregnant and parturient women as well as in the newborn.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2714506     DOI: 10.1016/0028-2243(89)90007-5

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  7 in total

1.  An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus.

Authors:  M Andrew; L Mitchell; L Berry; B Paes; M Delorme; F Ofosu; R Burrows; B Khambalia
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

Review 2.  DIC in Pregnancy - Pathophysiology, Clinical Characteristics, Diagnostic Scores, and Treatments.

Authors:  Offer Erez; Maha Othman; Anat Rabinovich; Elad Leron; Francesca Gotsch; Jecko Thachil
Journal:  J Blood Med       Date:  2022-01-06

3.  The pattern and magnitude of "in vivo thrombin generation" differ in women with preeclampsia and in those with SGA fetuses without preeclampsia.

Authors:  Offer Erez; Roberto Romero; Edi Vaisbuch; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Tinnakorn Chaiworapongsa; Francesca Gotsch; Pooja Mittal; Samuel S Edwin; Chia-Ling Nhan-Chang; Nandor Gabor Than; Chong Jai Kim; Sun Kwon Kim; Lami Yeo; Moshe Mazor; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2017-05-23

4.  Changes in amniotic fluid concentration of thrombin-antithrombin III complexes in patients with preterm labor: evidence of an increased thrombin generation.

Authors:  Offer Erez; Roberto Romer; Edi Vaisbuch; Tinnakorn Chaiworapongsa; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Francesca Gotsch; Ricardo Gomez; Eli Maymon; Percy Pacora; Samuel S Edwin; Chong Jai Kim; Nandor Gabor Than; Pooja Mittal; Lami Yeo; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Moshe Mazor
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11

5.  Pyelonephritis during pregnancy: a cause for an acquired deficiency of protein Z.

Authors:  Jyh Kae Nien; Roberto Romero; Debra Hoppensteadt; Offer Erez; Jimmy Espinoza; Eleazar Soto; Juan Pedro Kusanovic; Francesca Gotsch; Chong Jai Kim; Pooja Mittal; Jawed Fareed; Joaquin Santolaya; Tinnakorn Chaiworapongsa; Samuel Edwin; Beth Pineles; Sonia Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2008-09

6.  Preeclampsia is associated with low concentrations of protein Z.

Authors:  Offer Erez; Debra Hoppensteadt; Roberto Romero; Jimmy Espinoza; Luis Goncalves; Jyh Kae Nien; Juan Pedro Kusanovic; Jawed Fareed; Francesca Gotsch; Beth Pineles; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2007-09

7.  Placental vascular pathology and increased thrombin generation as mechanisms of disease in obstetrical syndromes.

Authors:  Salvatore Andrea Mastrolia; Moshe Mazor; Giuseppe Loverro; Vered Klaitman; Offer Erez
Journal:  PeerJ       Date:  2014-11-18       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.